Emergent BioSolutions Inc. (EBS): Capital Expenditures
$13.80M
Year ended 2025-12-31
$11.80M
Trailing 12 months to 2026-06-30
-50.8%
3-year compound annual growth
-37.3%
5-year compound annual growth
-11.1%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $13.80M | -39.7% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $22.90M | -55.6% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $51.60M | -55.4% | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | $115.80M | -48.3% | 2025-03-04, From 2022-01-01 |
| 2021-12-31 | $224.10M | +57.9% | 2024-03-08, From 2021-01-01 |
| 2020-12-31 | $141.90M | +63.3% | 2023-12-11, From 2020-01-01 |
| 2019-12-31 | $86.90M | +20.5% | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | $72.10M | +31.6% | 2021-02-19, From 2018-01-01 |
| 2017-12-31 | $54.80M | -28.1% | 2020-02-25, From 2017-01-01 |
| 2016-12-31 | $76.20M | +70.0% | 2019-02-22, From 2016-01-01 |
| 2015-12-31 | $44.81M | +46.1% | 2018-02-23, From 2015-01-01 |
| 2014-12-31 | $30.67M | -27.0% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $42.02M | -22.0% | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | $53.84M | -0.3% | 2015-03-09, From 2012-01-01 |
| 2011-12-31 | $54.03M | +144.5% | 2014-03-10, From 2011-01-01 |
| 2010-12-31 | $22.10M | -33.6% | 2013-03-08, From 2010-01-01 |
| 2009-12-31 | $33.29M | n/a | 2012-03-09, From 2009-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $13.80M | -39.7% |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $15.33M | +44.2% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $211.0K | -90.3% |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $34.88M | -15.0% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | $1.34M | +84.6% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $1.74M | +5.3% |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $1.57M | +466.1% |
| Ultragenyx Pharmaceutical Inc. (RARE) | 2025-12-31 | $6.00M | -14.3% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $22.67M | -84.0% |
Compare EBS, PCRX, CORT, AMPH side by side · Screen every company in Pharmaceutical Preparations ↗